Real-world smartphone keyboard interactions discriminates between different levels of disability in multiple sclerosis

被引：0
|
作者：
Lam, K.
Hoeijmakers, A.
Licitra, G.
Meijer, K.
Killestein, J.
机构：
来源：
EUROPEAN JOURNAL OF NEUROLOGY | 2021年 / 28卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
EPR-114
引用
收藏
页码：281 / 282
页数：2
相关论文
共 50 条
  • [41] Real-world walking in multiple sclerosis: Separating capacity from behavior
    Engelhard, Matthew M.
    Patek, Stephen D.
    Lach, John C.
    Goldman, Myla D.
    GAIT & POSTURE, 2018, 59 : 211 - 216
  • [42] Real-World Fingolimod efficacy and safety in Emirati patients with multiple sclerosis
    Ceccarelli, Antonia
    Mifsud, Victoria
    Elhennawy, Rawan Yasser Gaber
    Benedetti, Beatrice
    Hussain, Syed
    Samples, Stephen
    NEUROLOGY, 2019, 92 (15)
  • [43] The real-world patient experience of fingolimod and dimethyl fumarate for multiple sclerosis
    Wicks P.
    Rasouliyan L.
    Katic B.
    Nafees B.
    Flood E.
    Sasané R.
    BMC Research Notes, 9 (1)
  • [44] Real-world experience of ocrelizumab in multiple sclerosis patients in latin america
    Rojas, J.
    Patrucco, L.
    Fruns, M.
    Flores-Rivera, J.
    Carnero Contentti, E.
    Galleguillos, L.
    Alonso, R.
    Cristiano, E.
    MULTIPLE SCLEROSIS JOURNAL, 2020, 26 (3_SUPPL) : 548 - 548
  • [45] Real-World Outcomes With Cladribine Tablets in People With Relapsing Multiple Sclerosis
    Okuda, Darin
    Livingston, Terrie
    Moog, Tatum
    Smith, Alexander
    Lebson, Lori
    Piette, Elizabeth
    MULTIPLE SCLEROSIS JOURNAL, 2023, 29 : 1100 - 1100
  • [46] Real-World Use of Wearable Devices in a Large Multiple Sclerosis Cohort
    Foschini, Luca
    Medin, Jennie
    Bezlyak, Vladimir
    Stuck, David
    Silva, Diego
    Lee, Wei-Nchih
    NEUROLOGY, 2018, 90
  • [47] Immunological consequences of cladribine treatment in multiple sclerosis: A real-world study
    Rolfes, Leoni
    Pfeuffer, Steffen
    Huntemann, Niklas
    Schmidt, Mariella
    Su, Chuanxin
    Skuljec, Jelena
    Aslan, Derya
    Hackert, Jana
    Kleinschnitz, Konstanze
    Hagenacker, Tim
    Pawlitzki, Marc
    Ruck, Tobias
    Kleinschnitz, Christoph
    Meuth, Sven G.
    Pul, Refik
    MULTIPLE SCLEROSIS AND RELATED DISORDERS, 2022, 64
  • [48] Safety and effectiveness of natalizumab in a real-world multiple sclerosis Portuguese population
    Sequeira, M.
    Ferro, M.
    Barros, A.
    Sousa, A.
    Sequeira, J.
    Parra, J.
    Brum, M.
    Pedrosa, R.
    Capela, C.
    MULTIPLE SCLEROSIS JOURNAL, 2019, 25 : 868 - 869
  • [49] A real-world cohort analysis of alemtuzumab outcomes in relapsing multiple sclerosis
    Herman, Jorge Acevedo
    Khalighinejad, Farnaz
    York, Katherine
    Radu, Irina
    Morales, Idanis Berrios
    Ionete, Carolina
    Hemond, Christopher C.
    MULTIPLE SCLEROSIS AND RELATED DISORDERS, 2021, 47
  • [50] Leveraging Real-World Evidence and Observational Studies in Treating Multiple Sclerosis
    Aboseif, Albert
    Roos, Izanne
    Krieger, Stephen
    Kalincik, Tomas
    Hersh, Carrie M.
    NEUROLOGIC CLINICS, 2024, 42 (01) : 203 - 227
12345